P7488
Protein A−Alkaline Phosphatase
protein A from Staphylococcus aureus
Synonym(s):
Protein A−AP
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
biological source
protein A from Staphylococcus aureus
Quality Level
conjugate
alkaline phosphatase conjugate
color
clear light yellow
storage temp.
2-8°C
General description
Protein A is a 42 kD cell surface protein isolated from Staphylococcus aureus. It exists in secreted as well as membrane associated forms and has high binding affinity for immunoglobulins. So, this property is useful for the labeling and purification of antibodies. Protein A−Alkaline Phosphatase can be used in immunoblotting to analyse the IgG glycosylation. Protein A−Alkaline Phosphatase has specificity for most of the mammals except goat, sheep and rat.
Application
Protein A−alkaline phosphatase may be used in ELISA for analysis of IgG glycosylation.
Physical form
Solution at approx. 1 mg protein/ml in 50 mM Tris, pH 8.0, 1.0 mM magnesium chloride, 0.1 mM ZnCl2, 1% bovine serum albumin, 50% glycerol, and 15 mM sodium azide.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage Class Code
10 - Combustible liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Lisa D MacDonald et al.
Human vaccines & immunotherapeutics, 14(1), 59-66 (2017-09-22)
Peptide antigens are combined with an adjuvant in order to increase immunogenicity in vivo. The immunogenicity and safety of a RSV vaccine formulated in a novel oil-based platform, DepoVax™ (DPX), was compared to an alum formulation. A peptide B cell
A Croce et al.
Journal of clinical laboratory analysis, 21(5), 303-314 (2007-09-12)
In patients with rheumatoid arthritis (RA) a decrease in the terminal galactose content of N-linked glycans of the Fc region of agalactosyl immunoglobulin G (IgG) (G0) occurs. The aim of this study was to evaluate, for the first time, the
B N Ogunro et al.
Journal of epidemiology and global health, 8(3-4), 162-170 (2019-03-14)
Ebola viruses (family: Filoviridae) are the cause of Ebola virus disease (EVD), a highly fatal illness characterised by haemorrhagic fever syndrome in both humans and non-human primates (NHPs). West Africa was the epicentre of the 2013-2015 EVD epidemic which caused
M Graille et al.
Proceedings of the National Academy of Sciences of the United States of America, 97(10), 5399-5404 (2000-05-11)
Staphylococcus aureus produces a virulence factor, protein A (SpA), that contains five homologous Ig-binding domains. The interactions of SpA with the Fab region of membrane-anchored Igs can stimulate a large fraction of B cells, contributing to lymphocyte clonal selection. To
Kevin Morgan et al.
BMC cancer, 11, 476-476 (2011-11-05)
Gonadotrophin releasing hormone (GnRH) analogs lower estrogen levels in pre-menopausal breast cancer patients. GnRH receptor (GnRH-R) activation also directly inhibits the growth of certain cells. The applicability of GnRH anti-proliferation to breast cancer was therefore analyzed. GnRH-R expression in 298
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service